Toshiro Okazaki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Toshiro Okazaki has a total of 42 co-authors. Here are the top co-authors by number of shared publications:
Yoshio Hirabayashi
Laboratory for Molecular Membrane Neuroscience, Brain Science Institute, RIKEN, Japan
4 shared publicationsHisanori Umehara
Department of Hematology and Oncology, Clinical Sciences for Pathological Organs, Graduate School of Medicine, Kyoto University, Kyoto, Japan
3 shared publicationsMasaro Tashima
From the ‡Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Syogoin-Kawaramachi, Sakyo-ku, Kyoto 606-8507, the ¶Department of Medicine, Osaka Dental University, 1-5-17 Otemae, Cyo-ku, Osaka 540, and ‖Gene Bank, Tsukuba Life Science Research Center, Rikagakukenkyuusyo (RIKEN), 3-1-1 Takanodai, Tsukuba, Ibaraki 305-0074, Japan
3 shared publicationsAkihito Nishi
Laboratory of Biochemistry, Azabu University School of Veterinary Medicine, Japan
2 shared publicationsNaochika Domae
From the ‡Department of Hematology and Oncology, Graduate School of Medicine, Kyoto University, 54 Syogoin-Kawaramachi, Sakyo-ku, Kyoto 606-8507, the ¶Department of Medicine, Osaka Dental University, 1-5-17 Otemae, Cyo-ku, Osaka 540, and ‖Gene Bank, Tsukuba Life Science Research Center, Rikagakukenkyuusyo (RIKEN), 3-1-1 Takanodai, Tsukuba, Ibaraki 305-0074, Japan
2 shared publicationsShota Sakai
Laboratory of Biomembrane and Biofunctional Chemistry, Faculty of Advanced Life Science, Hokkaido University, Japan
2 shared publications
Latest Publications
- 1 October 2016
- Published by Elsevier in Journal of Dermatological Science
- Vol. 84 (1) , e153
Roles of two sphingomyelin synthase isoforms in murine hair
- 1 October 2016
- Published by Elsevier in Journal of Dermatological Science
- Vol. 84 (1) , e153
Roles of two sphingomyelin synthase isoforms in murine hair
- 1 October 2016
- Published by Elsevier in Journal of Dermatological Science
- Vol. 84 (1) , e129
Sphingomyelin synthase knockout mice exhibit an ichthyotic phenotype with epidermal lipid abnormalities
- 1 October 2016
- Published by Elsevier in Journal of Dermatological Science
- Vol. 84 (1) , e129
Sphingomyelin synthase knockout mice exhibit an ichthyotic phenotype with epidermal lipid abnormalities
- 1 November 2007
- Published by Bentham Science Publishers Ltd. in Current Immunology Reviews
- Vol. 3 (4) , 289-296
Sjogrens Syndrome and Lymphoma Development
Primary Sjogrens syndrome (pSS) is a systemic as well as an organ-specific autoimmune disease characterized by lymphocytic infiltration of the glandular epithelial tissue. It has been reported that pSS patients have a relatively increased risk for the development of lymphoma and various factors such as cytokine stimulation, environmental exposures and viral infections as well as genetic events may contribute to the development of lymphoma in pSS patients. Over the past few decades, numerous efforts have been undertaken to search for the relationship between lymphoma and pSS, for example advances in molecular biology for clonality analysis and well-linked register cohort studies for the predictive value of clinical, laboratory and histological findings. Despite this, mechanisms and prediction of lymphoma development in pSS patients still remain to be defined. In this review we have summarized the current knowledge concerning incidence and risk factors of lymphoma development in pSS patients. In addition, the most recent discoveries in the emergence and treatment of lymphoma in pSS patients and the possible mechanism of lymphoma development are also discussed.
- 1 November 2007
- Published by Bentham Science Publishers Ltd. in Current Immunology Reviews
- Vol. 3 (4) , 289-296
Sjogrens Syndrome and Lymphoma Development
Primary Sjogrens syndrome (pSS) is a systemic as well as an organ-specific autoimmune disease characterized by lymphocytic infiltration of the glandular epithelial tissue. It has been reported that pSS patients have a relatively increased risk for the development of lymphoma and various factors such as cytokine stimulation, environmental exposures and viral infections as well as genetic events may contribute to the development of lymphoma in pSS patients. Over the past few decades, numerous efforts have been undertaken to search for the relationship between lymphoma and pSS, for example advances in molecular biology for clonality analysis and well-linked register cohort studies for the predictive value of clinical, laboratory and histological findings. Despite this, mechanisms and prediction of lymphoma development in pSS patients still remain to be defined. In this review we have summarized the current knowledge concerning incidence and risk factors of lymphoma development in pSS patients. In addition, the most recent discoveries in the emergence and treatment of lymphoma in pSS patients and the possible mechanism of lymphoma development are also discussed.
- 19 October 2007
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 362 (2) , 252-255
Immunohistochemical distribution of phosphatidylglucoside using anti-phosphatidylglucoside monoclonal antibody (DIM21)
- 19 October 2007
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 362 (2) , 252-255
Immunohistochemical distribution of phosphatidylglucoside using anti-phosphatidylglucoside monoclonal antibody (DIM21)
- Open Access
- 1 September 2004
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 64 (17) , 6271-6279
Ceramide Reduction and Transcriptional Up-Regulation of Glucosylceramide Synthase through Doxorubicin-Activated Sp1 in Drug-Resistant HL-60/ADR Cells
Treatment with doxorubicin (DOX) induced apoptosis with an increase of ceramide content in drug-sensitive HL-60 cells, but not in drug-resistant HL-60/ADR cells. In HL-60/ADR cells (but not in HL-60 cells), the levels of mRNA, protein, and activity in glucosylceramide synthase (GCS), which converts ceramide to glucosylceramide, were up-regulated in response to DOX. Thus, abrogation of apoptosis in HL-60/ADR cells might be involved in ceramide reduction through DOX-induced up-regulation of GCS function. Because we reported that a GC-rich/Sp1 promoter binding region was of importance in the regulation of GCS expression, the role of Sp1 in DOX-induced up-regulation of GCS and apoptosis was investigated. DOX induced Sp1 activation in HL-60/ADR cells, as assessed by Sp1 gel shift and promoter-luciferase reporter assays, whereas transfection of double-stranded oligodeoxynucleotides (ODNs) containing a GC-rich/Sp1 region (Sp1 decoy ODNs) inhibited DOX-induced Sp1 activation. In addition, DOX-increased mRNA and enzyme activity in GCS were inhibited by Sp1 decoy, in conjunction with corresponding elevations of ceramide content. Moreover, DOX-induced apoptotic cell death was significantly increased in Sp1 decoy ODN-transfected HL-60/ADR cells over mock-transfected HL-60/ADR cells. Together, the results suggest that transcriptional up-regulation of GCS through DOX-induced activation of Sp1 is one potential mechanism to regulate ceramide increase and apoptosis in HL-60/ADR cells.
- 1 September 2004
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 64 (17) , 6271-6279
Open AccessCeramide Reduction and Transcriptional Up-Regulation of Glucosylceramide Synthase through Doxorubicin-Activated Sp1 in Drug-Resistant HL-60/ADR Cells
Treatment with doxorubicin (DOX) induced apoptosis with an increase of ceramide content in drug-sensitive HL-60 cells, but not in drug-resistant HL-60/ADR cells. In HL-60/ADR cells (but not in HL-60 cells), the levels of mRNA, protein, and activity in glucosylceramide synthase (GCS), which converts ceramide to glucosylceramide, were up-regulated in response to DOX. Thus, abrogation of apoptosis in HL-60/ADR cells might be involved in ceramide reduction through DOX-induced up-regulation of GCS function. Because we reported that a GC-rich/Sp1 promoter binding region was of importance in the regulation of GCS expression, the role of Sp1 in DOX-induced up-regulation of GCS and apoptosis was investigated. DOX induced Sp1 activation in HL-60/ADR cells, as assessed by Sp1 gel shift and promoter-luciferase reporter assays, whereas transfection of double-stranded oligodeoxynucleotides (ODNs) containing a GC-rich/Sp1 region (Sp1 decoy ODNs) inhibited DOX-induced Sp1 activation. In addition, DOX-increased mRNA and enzyme activity in GCS were inhibited by Sp1 decoy, in conjunction with corresponding elevations of ceramide content. Moreover, DOX-induced apoptotic cell death was significantly increased in Sp1 decoy ODN-transfected HL-60/ADR cells over mock-transfected HL-60/ADR cells. Together, the results suggest that transcriptional up-regulation of GCS through DOX-induced activation of Sp1 is one potential mechanism to regulate ceramide increase and apoptosis in HL-60/ADR cells.
- 1 March 2002
- Vol. 47, 438-41
[Signal transduction of ceramide].
- Open Access
- 1 March 2000
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 275 (12) , 8872-8879
Suppression of Heat Shock Protein-70 by Ceramide in Heat Shock-induced HL-60 Cell Apoptosis
- 1 March 2000
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 275 (12) , 8872-8879
Open AccessSuppression of Heat Shock Protein-70 by Ceramide in Heat Shock-induced HL-60 Cell Apoptosis
- 1 November 1998
- Published by Elsevier in Cellular Signalling
- Vol. 10 (10) , 685-692
Diversity and Complexity of Ceramide Signalling in Apoptosis
- 1 November 1998
- Published by Elsevier in Cellular Signalling
- Vol. 10 (10) , 685-692
Diversity and Complexity of Ceramide Signalling in Apoptosis
- Open Access
- 1 January 1997
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 272 (4) , 2452-2458
Ceramide-induced Translocation of Protein Kinase C-δ and -ϵ to the Cytosol
- 1 January 1997
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 272 (4) , 2452-2458
Open AccessCeramide-induced Translocation of Protein Kinase C-δ and -ϵ to the Cytosol